MESO MESOBLAST LTD

Nasdaq mesoblast.com


$ 17.17 $ -1.19 (-6.48 %)    

Wednesday, 22-Oct-2025 19:23:23 EDT
QQQ $ 605.88 $ 0.00 (0 %)
DIA $ 464.69 $ 0.00 (0 %)
SPY $ 668.10 $ 0.00 (0 %)
TLT $ 91.57 $ 0.00 (0 %)
GLD $ 379.10 $ 0.00 (0 %)
$ 17.18
$ 17.63
$ 15.50 x 250
$ 20.00 x 1
-- - --
$ 7.09 - $ 22.00
212,042
na
4.4B
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-sunday-mesoblast-q1-revenue-surges-to-206m-as-ryoncil-net-sales-jump-69-driven-by-wider-physician-adoption-and-reimbursement

Revenue from cell therapy products was US$20.6 million, up from US$12.9 million in the previous quarter ended June 30, 2025, an...

 mesoblast-shares-are-rising-higher-whats-behind-the-move

Mesoblast Limited (NASDAQ:MESO) shares are trading higher on Friday after the company announced that Ryoncil received a J-Code ...

 mesoblast-fy-eps-009-misses-005-estimate-sales-1720m-up-from-590m-yoy

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) b...

 independent-bank-posts-upbeat-earnings-joins-blaize-holdings-interactive-brokers-group-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION